Mark Lee
Analyst
Unspecified Title
Equibles does not estimate personal net worth.
Get an email with a short summary when HUTCHMED (China) Ltd publishes a filing, an earnings call transcript or a press release.
Get HCM alertsAbout Mark Lee
Mark Lee is recorded as Analyst at Unspecified Title. ICF International, Inc. reported in an 8-K filed December 4, 2023 that Mark Lee resigned as Executive Vice President of ICF International, Inc., effective January 5, 2024. The proxy statement of ICF International, Inc. reports total compensation of $1,615,587 for Mark Lee in fiscal 2022, including a base salary of $486,200. Disclosed compensation is on record for 2 fiscal years. HUTCHMED (China) Ltd is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“On December 4, 2023, ICF International, Inc. (the "Company") announced that Mr. Mark Lee, Executive Vice President of ICF International, Inc., would be leaving the Company to pursue other opportunities.”
Affiliation history
-
HUTCHMED (China) Ltd (HCM)
Source not stated
Current -
Unspecified Title
Analyst
Source not stated
Current -
ICF International, Inc. (ICFI)
Proxy statement
Start not stated–2024-01-05
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | ICF International, Inc. (ICFI) | Former Executive Vice President and Chief Technology Executive | $486,200 | $1,615,587 |
| 2021 | ICF International, Inc. (ICFI) | Former Executive Vice President and Chief Technology Executive | $467,500 | $1,000,242 |